مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

173
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

70
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Inhibition of herpes simplex virus type 1 replication by novel hsa-miR-7704 in vitro

Pages

  167-174

Abstract

 Herpes simplex virus type 1 (HSV-1) infections are one of the most common diseases in human population. HSV-1 causes subclinical, mild to severe diseases, especially in immunocompromised patients. Acyclovir has been used to reduce manifestations of HSV-1 infections. The extensive use of this drug has led to the development of resistant strains. Thus, designing a novel anti-herpes drug with different mechanisms of action is urgently needed. Cellular microRNAs (miRNAs) have direct antiviral effects in addition to their regulatory functions. In this study we used a novel miRNA (hsa-miR-7704), expressed in macrophages, to inhibit HSV-1 lytic infection in HeLa cells. Synthesized hsa-miR-7704 mimics were transfected into HSV-1 infected HeLa cell. The inhibitory effects of the miRNA were evaluated by plaque assay, real time polymerase chain reaction and the viral titers were measured by the 50% tissue culture infective dose (TCID50). The viral titer and cell cytopathic effect were dramatically decreased in HeLa cells transfected with hsa-miR-7704 (50 and 100 nM), compared with HSV-1 infected cells alone or transfected with the mock miRNA control. These results suggest that hsa-miR-7704 inhibits HSV-1 replication efficiently in vitro. This may provide an alternative mechanism to prevent HSV-1 infections.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    Shabani, Mehdi, NASR ESFAHANI, BAHRAM, Sadegh Ehdaei, Bahar, MOGHIM, SHARAREH, MIRZAEI, AREZOO, SHARIFI, MOHAMMADREZA, & MOUHEBAT, LEILI. (2019). Inhibition of herpes simplex virus type 1 replication by novel hsa-miR-7704 in vitro. RESEARCH IN PHARMACEUTICAL SCIENCES (RPS), 14(2), 167-174. SID. https://sid.ir/paper/738807/en

    Vancouver: Copy

    Shabani Mehdi, NASR ESFAHANI BAHRAM, Sadegh Ehdaei Bahar, MOGHIM SHARAREH, MIRZAEI AREZOO, SHARIFI MOHAMMADREZA, MOUHEBAT LEILI. Inhibition of herpes simplex virus type 1 replication by novel hsa-miR-7704 in vitro. RESEARCH IN PHARMACEUTICAL SCIENCES (RPS)[Internet]. 2019;14(2):167-174. Available from: https://sid.ir/paper/738807/en

    IEEE: Copy

    Mehdi Shabani, BAHRAM NASR ESFAHANI, Bahar Sadegh Ehdaei, SHARAREH MOGHIM, AREZOO MIRZAEI, MOHAMMADREZA SHARIFI, and LEILI MOUHEBAT, “Inhibition of herpes simplex virus type 1 replication by novel hsa-miR-7704 in vitro,” RESEARCH IN PHARMACEUTICAL SCIENCES (RPS), vol. 14, no. 2, pp. 167–174, 2019, [Online]. Available: https://sid.ir/paper/738807/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button